Articles published in Pharmacognosy Communications

Export 23 results:
Author Title Type [ Year(Asc)]
Filters: Keyword is Antibacterial activity  [Clear All Filters]
Mpala LNomathemba, Chikowe GRumbudzai, Cock IEdwin. Aleurites moluccanus (l.) Willd. Extracts Inhibit the Growth of Bacterial Triggers of Selected Autoimmune Inflammatory Diseases. Pharmacognosy Communications,. 2017;7(2):83-90.  (958.1 KB)
Cock IEdwin. Australian Acacia spp. extracts as natural food preservatives: Growth inhibition of food spoilage and food poisoning bacteria. Pharmacognosy Communications. 2017;7(1):4-15.  (1.6 MB)
Chikowe GRumbudzai, Mpala LNomathemba, Cock IEdwin. Cinnamomum Oliveri F. M. Bailey Leaf Solvent Extractions Inhibit the Growth of a Panel of Pathogenic Bacteria. Pharmacognosy Communications,. 2017;7(2):76-82.  (781.35 KB)
Bryant K, Cock IEdwin. Eupomatia laurina R. Br. fruit solvent extractions inhibit the growth of a panel of pathogenic bacteria. Pharmacognosy Communications. 2017;7(1):16-23.  (1 MB)
Chikowe GRumbudzai, Mpala LNomathemba, Cock IEdwin. Inhibition of the Growth of a Panel of Pathogenic Bacteria by Kunzea flavescens C.T. White and W.D. Francis Solvent Extractions. Pharmacognosy Communications,. 2017;7(3):121-128.  (1.48 MB)
Wright MHenry, Greene ACarlson, Cock IEdwin. Investigating the Pharmacognostic Potential of Indian Terminalia Spp. in the Treatment and Prevention of Yersiniosis. Pharmacognosy Communications,. 2017;7(3):108-113.  (795.67 KB)
Chikowe GRumbudzai, Mpala LNomathemba, Cock IEdwin. Swainsona Formosa (G.Don) Joy Thomp. Solvent Extractions Inhibit the Growth of a Panel of Pathogenic Bacteria. Journal of Young Pharmacists. 2017;7(2):91-97.  (828.61 KB)
Wigmore SM, Naiker M, Bean DC. Antimicrobial Activity of Extracts from Native Plants of Temperate Australia. Pharmacognosy Communications. 2016;6(2):80-84.  (304.7 KB)
Lebaratoux P, Sirdaarta J, Rayan P, PA MDPAnn McDonn, Cock IEdwin. An Evaluation of the Antibacterial, Anti-Giardial, Anticancer and Toxicity Properties of Selected Nut Extracts. Pharmacognosy Communications. 2016;6(3):174-184.  (934.41 KB)
Wright MHenry, Courtney R, Greene ACarlson, Cock IEdwin. Growth Inhibitory Activity of Indian Terminalia spp. against the Zoonotic Bacterium Bacillus anthracis. Pharmacognosy Communications. 2016;6(1):2-9.  (547.95 KB)
Bryant K, Cock IEdwin. Growth inhibitory properties of Backhousia myrtifolia Hook. & Harv. and Syzygium anisatum (Vickery) Craven & Biffen extracts against a panel of pathogenic bacteria. Pharmacognosy Communications. 2016;6(4):194-203.  (1.41 MB)
Mpala LNomathemba, Chikowe GRumbudzai, Cock IEdwin. Growth inhibitory properties of extracts prepared from selected Leptospermum and Melaleuca species against a panel of pathogenic bacteria. Pharmacognosy Communications. 2016;6(4):215-224.  (1.65 MB)
Wright MHenry, Arnold MSarah Jean, Lee CJay, Courtney R, Greene ACarlson, Cock IEdwin. Qualitative Phytochemical Analysis and Antibacterial Activity Evaluation of Indian Terminalia spp. Against the Pharyngitis Causing Pathogen Streptococcus pyogenes. Pharmacognosy Communications. 2016;6(2):85-92.  (673.21 KB)
Vallette L, Rabadeaux C, Sirdaarta J, Davis C, Cock IEdwin. An upscaled extraction protocol for Tasmannia lanceolata (Poir.) A.C. Sm.: Anti-bacterial, anti-Giardial and anticancer activity. Pharmacognosy Communications. 2016;6(4):238-254.  (1.44 MB)

Founded:  In 2004, as the PHCOG.NET – a non-profit private organization dedicated to Natural Products Research leading to develop promising drugs. Our main mission is to make information on herbal drug research readily available in different formats to suit the individual needs.

Pharmacognosy Communications [Phcog Commn.] is a new quarterly journal published by Phcog.Net. It is a peer reviewed journal aiming to publish high quality original research articles, methods, techniques and evaluation reports, critical reviews, short communications, commentaries and editorials of all aspects of medicinal plant research. The journal is aimed at a broad readership, publishing articles on all aspects of pharmacognosy, and related fields. The journal aims to increase understanding of pharmacognosy as well as to direct and foster further research through the dissemination of scientific information by the  publication of manuscripts. The submission of original contributions in all areas of pharmacognosy are welcome.

The journal aims to cater the latest outstanding developments in the field of pharmacognosy and natural products and drug design covering but not limited to the following topics:

  • Pharmacognosy and pharmacognistic investigations
  • Research based ethnopharmacological evaluations
  • Biological evaluation of crude extracts, essential oils and pure isolates
  • Natural product discovery and evaluation
  • Mechanistic studies
  • Method and technique development and evaluation
  • Isolation, identification and structural elucidation of natural products
  • Synthesis and transformation studies

Distinctions:  The most widely read, cited, and known Pharmacognosy Communications and website is well browsed with all the articles published. More than 20,000 readers in nearly every country in the world each month

Aim and Scope | Editorial Board | Indexed & Abstracted | Instruction to Authors | Manuscript Submission & Charges

Subjects Covered : Natural Products, Pharmacognosy, Phytochemistry, Marine Pharmacognosy and Zoo Pharmacognosy
ISSN :2249-0159 (Print) ; 2249-0167 (Online) Frequency : Quarterly Rapid at a time publication (4 issues/year)

Indexed and Abstracted in : Chemical Abstracts, Excerpta Medica / EMBASE, Google Scholar, CABI Full Text, Ulrich’s International Periodical Directory, ProQuest, Journalseek & Genamics, PhcogBase, EBSCOHost, Academic Search Complete, Open J-Gate, SciACCESS.
Rapid publication: Average time from submission to first decision is 30 days and from acceptance to In Press online  publication is 45 days.
Open Access Journal: Phcog Commn. is an open access journal, which allows authors to fund their article to be open access from publication.